Results 61 to 70 of about 430 (135)
“Missed” Diagnosis of Mycosis Fungoides: A Case Report
Clinical Case Reports, Volume 13, Issue 2, February 2025.ABSTRACT Mycosis fungoides (MF) is the most common subtype of primary cutaneous T‐cell lymphoma characterized by malignant proliferation of T cells with epidermotropism in the skin. MF has an indolent course, presents as erythematous scaly patches or plaques, and may progress to generalized erythroderma, cutaneous tumors, or extracutaneous invasion. MF
Mahesh Mathur +5 more
wiley +1 more source
JEADV Clinical Practice, Volume 3, Issue 5, Page 1660-1664, December 2024.Capsule Summary To date, the only potentially curative treatment option for advanced mycosis fungoides (MF) is allogeneic hematopoietic stem‐cell‐transplantation (alloHSCT). We report on a patient with MF who received allo‐HSCT due to rapid progression of the disease.
Inga Hansen‐Abeck +5 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 11, Page 1489-1497, November 2024.Summary Background Interferon‐alpha is an important therapeutic option for the treatment of the cutaneous T‐cell lymphomas (CTCL). Since the approved recombinant interferon‐α‐2a (IFN‐α2a) has no longer been produced since January 2020, pegylated interferon‐α2a (pegIFN‐α2a) can be used as an alternative treatment, even though it is not approved for the ...
Inga Hansen‐Abeck +20 more
wiley +1 more source
Ultra-high-frequency Ultrasound in the Objective Assessment of Chlormethine Gel Efficacy: A Case Report [PDF]
: Mycosis fungoides (MF) represent the most frequent form of cutaneous T-cell lymphoma (CTCL). Chlormethine gel has been approved as first-line therapy in MF.
Bevilacqua, Matteo +5 more
core +1 more source
Prospective observational study on the efficacy and tolerability of chlormethine gel in patients with Mycosis Fungoides and Sezary Syndrome [PDF]
La Micosi Fungoide (MF) è la forma più comune di linfoma cutaneo primitivo a cellule T ed è una malattia caratterizzata tipicamente da un decorso indolente nelle fasi iniziali e da prognosi infausta nelle fasi avanzate.
Guglielmo, Alba <1991>
core +1 more source
Comparison of Cisplatin and Nitrogen Mustard Derivatives in Cancer Treatment
, 2021 Platinum-containing complexes and nitrogen mustard derivatives are two drug families for cancer treatment. The two core drugs of the families were Cisplatin, created in 1845, and Chlormethine (mustine), created in 1925. Cisplatin is used to treat cancers
Liu, Ethan, Ung, Jane, Zhao, Qinliang
core
, 2016 In this work, a new conjugated polymer poly(fluorene-co-phenylene) derivative containing pendent quaternized chlormethine (PFP-Chl) was synthesized by covalent linking small molecular prodrug groups onto conjugated polymer side chains.
Shengliang Li (1428484) +6 more
core +1 more source
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection. [PDF]
Acta Derm Venereol, 2023 Gosmann J +4 more
europepmc +1 more source
BackgroundTopical chlormethine (CL) is recommended as a first-line treatment for early-stage mycosis fungoides (MF) and in 2017, the European Medicines Agency approved the CL gel formulation to treat adult patients.
Cesare Massone (27168) +9 more
core +1 more source
DNA-Targeting Bioactive Photosensitizer for Chemo-Photodynamic Therapy of Malignant Tumor
The design of a biologically active photosensitizer that effectively combines chemotherapy and photodynamic therapy remains a significant challenge. This article introduces a DNA targeted biologically active photosensitizer, CQA, which integrates the DNA
Ling Li (38566) +10 more
core +1 more source